The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival

BACKGROUND: Lung cancer causes approximately one million deaths each year worldwide and protein p53 has been shown to be involved in the intricate processes regulating response to radiation and/or chemotherapeutic treatment. Consequently, since antibodies against p53 (anti-p53 antibodies) are associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergqvist, Michael, Brattström, Daniel, Larsson, Anders, Hesselius, Patrik, Brodin, Ola, Wagenius, Gunnar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC517936/
https://www.ncbi.nlm.nih.gov/pubmed/15367333
http://dx.doi.org/10.1186/1471-2407-4-66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC517936/
https://www.ncbi.nlm.nih.gov/pubmed/15367333
http://dx.doi.org/10.1186/1471-2407-4-66

Ejemplares similares